Which has the lower trailing P/E, ABT or PFE?

ABT has the lower trailing P/E: ABT trades at 33.02 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or PFE?

Over the past five years, PFE grew revenue faster — ABT at a 2.98% CAGR versus PFE at 6.29%.

Does ABT or PFE pay a bigger dividend?

ABT yields 2.43% and PFE yields 6.20% based on trailing dividends and the latest price.

Is ABT or PFE more profitable?

ABT runs the higher net margin — ABT at 11.65% versus PFE at 6.81%.

How have ABT and PFE total returns compared?

Over the past 10 years, ABT delivered 11.61% and PFE delivered 3.15% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Pfizer Inc. (PFE)

A side-by-side comparison of Abbott Laboratories and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$177.72B

$102.71HealthcareDelayed quote: Sep 14, 2026, 1:10 PM EDT

PFE

Pfizer Inc.

$158.02B

$27.73HealthcareDelayed quote: Sep 14, 2026, 1:09 PM EDT

Total return — ABT vs PFE

growth of $100 · dividends reinvested · last 10y

ABT +193.7% (+11.4%/yr)PFE +37.0% (+3.2%/yr)ABT compounded faster over this window

ABT PFE

ABT vs PFE: by the numbers

•ABT is the larger company ($177.72B vs $158.02B market cap).
•ABT trades at the lower trailing earnings multiple (33.02 vs 36.63 P/E), one valuation lens rather than an overall verdict.
•ABT converts more revenue to profit (11.65% vs 6.81% net margin).
•PFE grew revenue faster over the past five years (6.29% vs 2.98% CAGR).
•PFE pays the higher dividend yield (6.20% vs 2.43%).

Metrics side by side

Valuation

Metric	ABT	PFE
P/E ratio	33.02	36.63
Forward P/E	18.62	9.32
P/S ratio	3.81	2.48
P/B ratio	3.48	1.85
EV / EBITDA	18.85	10.15
FCF yield	4.46%	6.95%

Profitability

Metric	ABT	PFE
Gross margin	56.80%	71.32%
Operating margin	17.03%	25.08%
Net margin	11.65%	6.81%
ROE	10.61%	5.09%
ROIC	6.07%	9.33%

Dividends

Metric	ABT	PFE
Dividend yield	2.43%	6.20%
Payout ratio	79.74%	227.27%

Growth (annualized)

Metric	ABT	PFE
Revenue CAGR (5Y)	2.98%	6.29%
EPS CAGR (5Y)	8.22%	-3.78%
FCF CAGR (5Y)	0.18%	-3.11%
Total return CAGR (5Y)	-2.69%	-4.53%

Frequently asked

Which has the lower trailing P/E, ABT or PFE?: ABT has the lower trailing P/E: ABT trades at 33.02 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or PFE?: Over the past five years, PFE grew revenue faster — ABT at a 2.98% CAGR versus PFE at 6.29%.
Does ABT or PFE pay a bigger dividend?: ABT yields 2.43% and PFE yields 6.20% based on trailing dividends and the latest price.
Is ABT or PFE more profitable?: ABT runs the higher net margin — ABT at 11.65% versus PFE at 6.81%.
How have ABT and PFE total returns compared?: Over the past 10 years, ABT delivered 11.61% and PFE delivered 3.15% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Pfizer P/E ratio Abbott Laboratories dividend yield Pfizer dividend yield Abbott Laboratories ROE Pfizer ROE Abbott Laboratories operating margin Pfizer operating margin Abbott Laboratories revenue growth Pfizer revenue growth Abbott Laboratories free cash flow Pfizer free cash flow

Abbott Laboratories & Pfizer appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.